<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="suclg1-mtddepl" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">suclg1-mtddepl</book-part-id>
      <title-group>
        <title><italic toggle="yes">SUCLG1</italic>-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria</title>
        <alt-title alt-title-type="alt-title">Synonyms: SUCLG1 Deficiency, <italic toggle="yes">SUCLG1</italic>-Related Succinyl-CoA Ligase Deficiency</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>El-Hattab</surname>
            <given-names>Ayman W</given-names>
          </name>
          <degrees>MD, FAAP, FACMG</degrees>
          <aff>Division of Clinical Genetics and Metabolic Disorders<break/>Pediatric Department<break/>Tawam Hospital<break/>Al-Ain, United Arab Emirates</aff>
          <email>elhattabaw@yahoo.com</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Scaglia</surname>
            <given-names>Fernando</given-names>
          </name>
          <degrees>MD, FAAP, FACMG</degrees>
          <aff>Department of Molecular and Human Genetics<break/>Baylor College of Medicine<break/>Houston, Texas</aff>
          <email>fscaglia@bcm.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>30</day>
          <month>3</month>
          <year>2017</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="sucla2-def" document-type="chapter"><italic toggle="yes">SUCLA2</italic>-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="syne1ca-ar" document-type="chapter"><italic toggle="yes">SYNE1</italic>-Related Autosomal Recessive Cerebellar Ataxia</related-object>
      <abstract id="suclg1-mtddepl.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">SUCLG1</italic>-related mitochondrial DNA (mtDNA) depletion syndrome, encephalomyopathic form with methylmalonic aciduria is characterized in the majority of affected newborns by hypotonia, muscle atrophy, feeding difficulties, and lactic acidosis. Affected infants commonly manifest developmental delay / cognitive impairment, growth retardation / failure to thrive, hepatopathy, sensorineural hearing impairment, dystonia, and hypertonia. Notable findings in some affected individuals include hypertrophic cardiomyopathy, epilepsy, myoclonus, microcephaly, sleep disturbance, rhabdomyolysis, contractures, hypothermia, and/or hypoglycemia. Life span is shortened, with median survival of 20 months.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of <italic toggle="yes">SUCLG1</italic>-related mtDNA depletion syndrome is established in a proband by the identification of biallelic pathogenic variants in <italic toggle="yes">SUCLG1</italic> on molecular genetic testing.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Management is supportive and is best provided by a multidisciplinary team. Treatment may include physical therapy to help maintain muscle function and prevent joint contractures, nutritional support by a dietitian, use of a nasogastric tube or gastrostomy tube feedings, chest physiotherapy, and aggressive antibiotic treatment of chest infections. When present, seizures are treated using standard antiepileptic drugs.</p>
          <p><italic toggle="yes">Surveillance:</italic> The suggested evaluations (with frequency varying according to the needs of the child) can include developmental and neurologic assessment, nutritional and growth assessment, echocardiogram, liver function tests, hearing evaluation, and ophthalmologic examination.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p><italic toggle="yes">SUCLG1</italic>-related mtDNA depletion syndrome is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Once the <italic toggle="yes">SUCLG1</italic> pathogenic variants have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis are possible.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="suclg1-mtddepl.Diagnosis">
        <title>Diagnosis</title>
        <sec id="suclg1-mtddepl.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p><italic toggle="yes">SUCLG1</italic>-related mitochondrial DNA (mtDNA) depletion syndrome, encephalomyopathic form with methylmalonic aciduria (MMA) typically manifests at birth or during early infancy and <bold>should be suspected</bold> in individuals with a combination of the following supportive clinical, brain MRI, laboratory, and muscle biopsy findings.</p>
          <p>
            <bold>Clinical features</bold>
          </p>
          <p>Present in &#x0003e;50%:</p>
          <list list-type="bullet">
            <list-item>
              <p>Developmental delay and cognitive impairment</p>
            </list-item>
            <list-item>
              <p>Hypotonia</p>
            </list-item>
            <list-item>
              <p>Muscle atrophy</p>
            </list-item>
            <list-item>
              <p>Feeding difficulties</p>
            </list-item>
          </list>
          <p>Present in 20%-50%:</p>
          <list list-type="bullet">
            <list-item>
              <p>Growth retardation / failure to thrive</p>
            </list-item>
            <list-item>
              <p>Hepatopathy</p>
            </list-item>
            <list-item>
              <p>Sensorineural hearing impairment</p>
            </list-item>
            <list-item>
              <p>Dystonia</p>
            </list-item>
            <list-item>
              <p>Hypertonia</p>
            </list-item>
          </list>
          <p>Present in &#x0003c;20%:</p>
          <list list-type="bullet">
            <list-item>
              <p>Hypertrophic cardiomyopathy</p>
            </list-item>
            <list-item>
              <p>Recurrent respiratory infections, respiratory distress, and apnea</p>
            </list-item>
            <list-item>
              <p>Recurrent vomiting and gastroesophageal reflux disease</p>
            </list-item>
            <list-item>
              <p>Ptosis and strabismus</p>
            </list-item>
            <list-item>
              <p>Epilepsy, myoclonus, and microcephaly</p>
            </list-item>
            <list-item>
              <p>Hyperhidrosis</p>
            </list-item>
            <list-item>
              <p>Sleep disturbance</p>
            </list-item>
            <list-item>
              <p>Rhabdomyolysis</p>
            </list-item>
            <list-item>
              <p>Contractures</p>
            </list-item>
            <list-item>
              <p>Hypothermia</p>
            </list-item>
          </list>
          <p><bold>Brain MRI findings</bold> [<xref ref-type="bibr" rid="suclg1-mtddepl.REF.carrozzo.2016.243">Carrozzo et al 2016</xref>]</p>
          <list list-type="bullet">
            <list-item>
              <p>Basal ganglia hyperintensities (80%)</p>
            </list-item>
            <list-item>
              <p>Cerebral atrophy (30%)</p>
            </list-item>
            <list-item>
              <p>Leukoencephalopathy (20%)</p>
            </list-item>
          </list>
          <p>
            <bold>Supportive laboratory findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>
                <bold>Urine organic acid analysis</bold>
              </p>
              <list list-type="bullet">
                <list-item>
                  <p>Elevation of urinary methylmalonic acid (MMA) in all affected children. Urinary MMA ranges from 10-500 mmol/mol creatinine (normal &#x0003c;3 mmol/mol creatinine).</p>
                  <p>Note: In classic <related-object link-type="booklink" source-id="gene" document-id="mma" document-type="chapter">methylmalonic aciduria</related-object> urinary MMA is ~1,000-10,000 mmol/mol creatinine, and in defects of cobalamin metabolism urinary MMA is ~100s mmol/mol creatinine (see <xref ref-type="sec" rid="suclg1-mtddepl.Differential_Diagnosis">Differential Diagnosis</xref>).</p>
                </list-item>
                <list-item>
                  <p>Several other metabolites that may be elevated in urine include methylcitrate, 3-methylglutaconic acid, 3-hydroxyisovaleric acid, and Krebs cycle intermediates (e.g., succinate, fumarate, 2-ketoglutarate).</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Plasma MMA level</bold> is elevated in all affected children and ranges from 1 to10 mmol/L (normal &#x0003c;0.3 mmol/L). Note: In classic <related-object link-type="booklink" source-id="gene" document-id="mma" document-type="chapter">methylmalonic aciduria</related-object> plasma MMA is ~100-1,000 mmol/L, and in defects of cobalamin metabolism plasma MMA is ~10s mmol/L (see <xref ref-type="sec" rid="suclg1-mtddepl.Differential_Diagnosis">Differential Diagnosis</xref>).</p>
            </list-item>
            <list-item>
              <p><bold>Acylcarnitine profile</bold> can show elevated C3; thus, this condition can potentially be detected by newborn screening.</p>
            </list-item>
            <list-item>
              <p><bold>Plasma and CSF lactate levels</bold> are elevated in most affected individuals.</p>
            </list-item>
            <list-item>
              <p><bold>Hypoglycemia</bold> can occasionally occur [<xref ref-type="bibr" rid="suclg1-mtddepl.REF.carrozzo.2016.243">Carrozzo et al 2016</xref>].</p>
            </list-item>
          </list>
          <p><bold>Muscle biopsy</bold>, typically performed during the evaluation of individuals with mitochondrial diseases, can show variable abnormalities or can occasionally be normal. The following findings can suggest the diagnosis:</p>
          <list list-type="bullet">
            <list-item>
              <p>Increased fiber size variability, atrophic fibers, intracellular lipid accumulation, ragged-red fibers (RRF), and COX-deficient fibers</p>
            </list-item>
            <list-item>
              <p>Structurally altered mitochondria with abnormal cristae on electron microscopy</p>
            </list-item>
            <list-item>
              <p>Abnormal electron transport chain activity. The most common abnormalities are combined complex I and IV deficiencies, combined complex I, III, and IV deficiencies, and isolated complex IV deficiency.</p>
            </list-item>
            <list-item>
              <p>Reduced mtDNA content; typically 15%-50% of tissue- and age-matched controls [<xref ref-type="bibr" rid="suclg1-mtddepl.REF.ostergaard.2007.383">Ostergaard et al 2007</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.valayannopoulos.2010.335">Valayannopoulos et al 2010</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.randolph.2011.149">Randolph et al 2011</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.landsverk.2014">Landsverk et al 2014</xref>]</p>
            </list-item>
          </list>
        </sec>
        <sec id="suclg1-mtddepl.Establishing_the_Diagnosi">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of <italic toggle="yes">SUCLG1</italic>-related mtDNA depletion syndrome <bold>is established</bold> in a proband by the identification of biallelic pathogenic variants in <italic toggle="yes">SUCLG1</italic> on molecular genetic testing (see <xref ref-type="table" rid="suclg1-mtddepl.T.molecular_genetic_testi">Table 1</xref>).</p>
          <p>Molecular genetic testing approaches can include a combination of <bold>gene-targeted testing</bold> (multi-gene panel) and <bold>genomic testing</bold> (comprehensive genome sequencing) depending on the phenotype.</p>
          <p>Gene-targeted testing requires that the clinician determine which gene(s) are likely involved, whereas genomic testing does not. Because the phenotype of <italic toggle="yes">SUCLG1</italic>-related mtDNA depletion syndrome is broad, children with the distinctive findings described in <xref ref-type="sec" rid="suclg1-mtddepl.Suggestive_Findings">Suggestive Findings</xref> are likely to be diagnosed using gene-targeted testing (see <xref ref-type="sec" rid="suclg1-mtddepl.Option_1">Option 1</xref>), whereas those with a phenotype indistinguishable from other inherited mitochondrial disorders are more likely to be diagnosed using genomic testing (see <xref ref-type="sec" rid="suclg1-mtddepl.Option_2">Option 2</xref>).</p>
          <sec id="suclg1-mtddepl.Option_1">
            <title>Option 1</title>
            <p>The phenotypes of <italic toggle="yes">SUCLG1</italic>-related mtDNA depletion syndrome and <italic toggle="yes">SUCLA2</italic>-related mtDNA depletion syndrome are difficult to distinguish and both are associated with elevated MMA. Therefore, when the phenotypic and laboratory findings suggest the diagnosis of <italic toggle="yes">SUCLG1</italic>-related mtDNA depletion syndrome, molecular genetic testing approaches can include <bold><italic toggle="yes">SUCLG1</italic> and <italic toggle="yes">SUCLA2</italic> testing</bold> or use of a <bold>multi-gene panel</bold>:</p>
            <list list-type="bullet">
              <list-item>
                <p><bold><italic toggle="yes">SUCLG1</italic> and <italic toggle="yes">SUCLA2</italic> testing.</bold> Sequence analysis of <italic toggle="yes">SUCLG1</italic> and <italic toggle="yes">SUCLA2</italic> is performed first. If only one pathogenic variant is found, gene-targeted deletion/duplication analysis of that gene could be considered; however, to date no exon or whole-gene deletions of either gene have been reported.</p>
              </list-item>
              <list-item>
                <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">SUCLG1,</italic>
<italic toggle="yes">SUCLA2,</italic> and other genes related to <bold>mtDNA depletion syndromes</bold> (see <xref ref-type="sec" rid="suclg1-mtddepl.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: (1) The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of the condition at the most reasonable cost while limiting secondary findings. Of note, given the rarity of <italic toggle="yes">SUCLG1</italic>-related mtDNA depletion syndrome, some panels for mtDNA depletion syndromes may not include this gene. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests.</p>
                <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
              </list-item>
            </list>
          </sec>
          <sec id="suclg1-mtddepl.Option_2">
            <title>Option 2</title>
            <p>When the phenotype is indistinguishable from many other <bold>inherited mitochondrial disorders</bold> molecular genetic testing approaches can include <bold>genomic testing</bold> (comprehensive genome sequencing) and/or <bold>gene-targeted testing</bold> (multi-gene panel):</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Comprehensive genome sequencing</bold> (when clinically available) includes exome sequencing and genome sequencing. For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
              </list-item>
              <list-item>
                <p><bold>A multi-gene panel</bold> for <bold>inherited mitochondrial disorders</bold> may also be considered.</p>
              </list-item>
            </list>
            <table-wrap id="suclg1-mtddepl.T.molecular_genetic_testi" orientation="portrait" position="anchor">
              <label>Table 1. </label>
              <caption>
                <p>Molecular Genetic Testing Used in <italic toggle="yes">SUCLG1</italic>-Related mtDNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_suclg1-mtddepl.T.molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_suclg1-mtddepl.T.molecular_genetic_testi_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_h_suclg1-mtddepl.T.molecular_genetic_testi_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_suclg1-mtddepl.T.molecular_genetic_testi_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">SUCLG1</italic>
                    </td>
                    <td headers="hd_h_suclg1-mtddepl.T.molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                    <td headers="hd_h_suclg1-mtddepl.T.molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">21/21&#x000a0;<sup>4</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_suclg1-mtddepl.T.molecular_genetic_testi_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_suclg1-mtddepl.T.molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">None reported to date&#x000a0;<sup>4</sup></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="suclg1-mtddepl.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="suclg1-mtddepl" object-id="suclg1-mtddepl.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="suclg1-mtddepl.TF.1.2">
                  <label>2. </label>
                  <p>See <xref ref-type="sec" rid="suclg1-mtddepl.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
                </fn>
                <fn id="suclg1-mtddepl.TF.1.3">
                  <label>3. </label>
                  <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="suclg1-mtddepl.TF.1.4">
                  <label>4. </label>
                  <p>
                    <xref ref-type="bibr" rid="suclg1-mtddepl.REF.carrozzo.2016.243">Carrozzo et al [2016]</xref>
                  </p>
                </fn>
                <fn id="suclg1-mtddepl.TF.1.5">
                  <label>5. </label>
                  <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
      </sec>
      <sec id="suclg1-mtddepl.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="suclg1-mtddepl.Clinical_Description">
          <title>Clinical Description</title>
          <p>To date 29 individuals with <italic toggle="yes">SUCLG1</italic>-related mitochondrial DNA (mtDNA) depletion syndrome, encephalomyopathic form with methylmalonic aciduria (MMA) have been reported [<xref ref-type="bibr" rid="suclg1-mtddepl.REF.ostergaard.2007.383">Ostergaard et al 2007</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.ostergaard.2010.201">Ostergaard et al 2010</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.rivera.2010.362">Rivera et al 2010</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.rouzier.2010.670">Rouzier et al 2010</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.valayannopoulos.2010.335">Valayannopoulos et al 2010</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.van_hove.2010.159">Van Hove et al 2010</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.randolph.2011.149">Randolph et al 2011</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.sakamoto.2011.921">Sakamoto et al 2011</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.honzik.2012.749">Honzik et al 2012</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.navarrosastre.2012.409">Navarro-Sastre et al 2012</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.landsverk.2014">Landsverk et al 2014</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.carrozzo.2016.243">Carrozzo et al 2016</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.chu.2016.264">Chu et al 2016</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.donti.2016.68">Donti et al 2016</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.liu.2016.61">Liu et al 2016</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.pupavac.2016.363">Pupavac et al 2016</xref>].</p>
          <p>The clinical description here is based on the findings reported in these 29 individuals. The common clinical manifestations are summarized in <xref ref-type="table" rid="suclg1-mtddepl.T.clinical_manifestations">Table 2</xref> [<xref ref-type="bibr" rid="suclg1-mtddepl.REF.carrozzo.2016.243">Carrozzo et al 2016</xref>].</p>
          <table-wrap id="suclg1-mtddepl.T.clinical_manifestations" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>Clinical Manifestations of <italic toggle="yes">SUCLG1</italic>-Related mtDNA Depletion Syndrome</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_suclg1-mtddepl.T.clinical_manifestations_1_1_1_1" valign="top" align="left" scope="col" rowspan="1" colspan="1">Frequency</th>
                  <th id="hd_h_suclg1-mtddepl.T.clinical_manifestations_1_1_1_2" valign="top" align="left" scope="col" rowspan="1" colspan="1">Manifestations</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_suclg1-mtddepl.T.clinical_manifestations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">&#x0003e;50%</td>
                  <td headers="hd_h_suclg1-mtddepl.T.clinical_manifestations_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Developmental delay and cognitive impairment</p></list-item><list-item><p>Hypotonia</p></list-item><list-item><p>Muscle atrophy</p></list-item><list-item><p>Feeding difficulties</p></list-item><list-item><p>Lactic acidosis</p></list-item></list>
</td>
                </tr>
                <tr>
                  <td headers="hd_h_suclg1-mtddepl.T.clinical_manifestations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">20%-50%</td>
                  <td headers="hd_h_suclg1-mtddepl.T.clinical_manifestations_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Growth retardation / failure to thrive</p></list-item><list-item><p>Hepatopathy</p></list-item><list-item><p>Sensorineural hearing impairment</p></list-item><list-item><p>Dystonia</p></list-item><list-item><p>Hypertonia</p></list-item></list>
</td>
                </tr>
                <tr>
                  <td headers="hd_h_suclg1-mtddepl.T.clinical_manifestations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">&#x0003c;20%</td>
                  <td headers="hd_h_suclg1-mtddepl.T.clinical_manifestations_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Hypertrophic cardiomyopathy</p></list-item><list-item><p>Recurrent respiratory infections</p></list-item><list-item><p>Respiratory distress</p></list-item><list-item><p>Apnea</p></list-item><list-item><p>Recurrent vomiting</p></list-item><list-item><p>Gastroesophageal reflux disease</p></list-item><list-item><p>Ptosis</p></list-item><list-item><p>Strabismus</p></list-item><list-item><p>Epilepsy</p></list-item><list-item><p>Myoclonus</p></list-item><list-item><p>Microcephaly</p></list-item><list-item><p>Choreoathetosis</p></list-item><list-item><p>Hyperhidrosis</p></list-item><list-item><p>Sleep disturbance</p></list-item><list-item><p>Rhabdomyolysis</p></list-item><list-item><p>Contractures</p></list-item><list-item><p>Hypothermia</p></list-item><list-item><p>Hypoglycemia</p></list-item></list>
</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
          <p><bold>Age of onset and phenotypic spectrum.</bold> Although <italic toggle="yes">SUCLG1</italic>-related mtDNA depletion syndrome can present from the prenatal period to age one year, the majority of affected infants present at birth [<xref ref-type="bibr" rid="suclg1-mtddepl.REF.carrozzo.2016.243">Carrozzo et al 2016</xref>].</p>
          <p>The majority have an uncomplicated pregnancy and normal birth weight; however, five neonates had intrauterine growth restriction (IUGR) or were small for gestational age (SGA) [<xref ref-type="bibr" rid="suclg1-mtddepl.REF.ostergaard.2007.383">Ostergaard et al 2007</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.randolph.2011.149">Randolph et al 2011</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.carrozzo.2016.243">Carrozzo et al 2016</xref>]. Rare prenatal manifestations may include oligohydramnios and abnormal fetal heart rate [<xref ref-type="bibr" rid="suclg1-mtddepl.REF.carrozzo.2016.243">Carrozzo et al 2016</xref>].</p>
          <p>The majority of affected infants present with early-onset encephalomyopathy and neurocognitive problems as well as hepatopathy, feeding and growth problems, and cardiorespiratory complications.</p>
          <p>Death from severe metabolic acidosis during the neonatal period (fatal infantile lactic acidosis) has been reported in five infants [<xref ref-type="bibr" rid="suclg1-mtddepl.REF.ostergaard.2007.383">Ostergaard et al 2007</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.rivera.2010.362">Rivera et al 2010</xref>].</p>
          <p><bold>Neurocognitive.</bold> The majority of affected children demonstrate developmental delay, cognitive impairment, hypotonia, and muscle atrophy. Other less frequent neurologic manifestations include: sensorineural hearing impairment, dystonia, hypertonia, epilepsy, myoclonus, microcephaly, choreoathetosis, ptosis, and strabismus.</p>
          <p><bold>Hepatopathy.</bold> Approximately 40% of affected individuals have liver involvement manifesting as hepatomegaly, steatosis, and elevated liver enzymes. One affected infant developed intermittent episodes of liver failure [<xref ref-type="bibr" rid="suclg1-mtddepl.REF.van_hove.2010.159">Van Hove et al 2010</xref>].</p>
          <p><bold>Feeding and growth.</bold> Failure to thrive, growth retardation, and feeding difficulties, often necessitating tube feeding, occur commonly. Recurrent vomiting and gastroesophageal reflux disease (GERD) occasionally occur. The feeding difficulties, recurrent vomiting, and GERD can cause or contribute to growth failure.</p>
          <p><bold>Cardiac.</bold> Hypertrophic cardiomyopathy was reported in 15% of affected children. Ventricular hypertrophy is typically mild and appears in the neonatal period or infancy [<xref ref-type="bibr" rid="suclg1-mtddepl.REF.carrozzo.2016.243">Carrozzo et al 2016</xref>].</p>
          <p><bold>Respiratory.</bold> Recurrent respiratory infections are reported in some. Respiratory distress due to muscle weakness, apnea, and abnormal breathing has been reported.</p>
          <p><bold>Congenital malformations.</bold> One affected infant had multiple congenital anomalies including cleft lip and palate, aortic coarctation, patent ductus arteriosus, patent foramen ovale, shortening of the left femur and both humeri, dilation of the left renal collecting system, and accessory left kidney [<xref ref-type="bibr" rid="suclg1-mtddepl.REF.landsverk.2014">Landsverk et al 2014</xref>].</p>
          <p>Other congenital anomalies reported in single infants each are interrupted aortic arch, polydactyly, and hypospadias [<xref ref-type="bibr" rid="suclg1-mtddepl.REF.ostergaard.2007.383">Ostergaard et al 2007</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.rivera.2010.362">Rivera et al 2010</xref>].</p>
          <p><bold>Metabolic derangements.</bold> In addition to elevated MMA, the majority of affected children develop lactic acidosis that can be severe and life threatening. Hypoglycemia was occasionally reported.</p>
          <p><bold>Others.</bold> Other less frequent manifestations include hyperhidrosis, hypothermia, sleeping disturbance, rhabdomyolysis, and joint contractures.</p>
          <p><bold>Prognosis.</bold> Life span is shortened, with median survival of 20 months. Two thirds (14/21) of affected children died during childhood &#x02013; five in the neonatal period and nine during infancy and early childhood [<xref ref-type="bibr" rid="suclg1-mtddepl.REF.carrozzo.2016.243">Carrozzo et al 2016</xref>].</p>
        </sec>
        <sec id="suclg1-mtddepl.GenotypePhenotype_Correla">
          <title>Genotype-Phenotype Correlations</title>
          <p>Pathogenic <italic toggle="yes">SUCLG1</italic> missense variants can result in some residual enzyme activity, and hence a milder phenotype. Survival in children with biallelic pathogenic missense variants was longer (median age: 18 months) than in children with biallelic loss-of-function variants (splice-site, frameshift, and nonsense variants) (median age: birth) [<xref ref-type="bibr" rid="suclg1-mtddepl.REF.carrozzo.2016.243">Carrozzo et al 2016</xref>].</p>
        </sec>
        <sec id="suclg1-mtddepl.Nomenclature">
          <title>Nomenclature</title>
          <p>Succinyl-CoA ligase deficiency can result from either biallelic pathogenic variants in <italic toggle="yes">SUCLG1</italic> (<italic toggle="yes">SUCLG1</italic>-related mtDNA depletion syndrome) or biallelic pathogenic variants in <italic toggle="yes">SUCLA2</italic> (<related-object link-type="booklink" source-id="gene" document-id="sucla2-def" document-type="chapter"><italic toggle="yes">SUCLA2</italic>-related mtDNA depletion syndrome</related-object>).</p>
        </sec>
        <sec id="suclg1-mtddepl.Prevalence">
          <title>Prevalence</title>
          <p><italic toggle="yes">SUCLG1</italic>-related mtDNA depletion syndrome is rare; the exact prevalence is unknown. To date 29 individuals with <italic toggle="yes">SUCLG1</italic>-related mtDNA depletion have been reported in families of different ethnic origins [<xref ref-type="bibr" rid="suclg1-mtddepl.REF.ostergaard.2007.383">Ostergaard et al 2007</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.ostergaard.2010.201">Ostergaard et al 2010</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.rivera.2010.362">Rivera et al 2010</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.rouzier.2010.670">Rouzier et al 2010</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.valayannopoulos.2010.335">Valayannopoulos et al 2010</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.van_hove.2010.159">Van Hove et al 2010</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.randolph.2011.149">Randolph et al 2011</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.sakamoto.2011.921">Sakamoto et al 2011</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.honzik.2012.749">Honzik et al 2012</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.navarrosastre.2012.409">Navarro-Sastre et al 2012</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.landsverk.2014">Landsverk et al 2014</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.carrozzo.2016.243">Carrozzo et al 2016</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.chu.2016.264">Chu et al 2016</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.donti.2016.68">Donti et al 2016</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.liu.2016.61">Liu et al 2016</xref>, <xref ref-type="bibr" rid="suclg1-mtddepl.REF.pupavac.2016.363">Pupavac et al 2016</xref>].</p>
        </sec>
      </sec>
      <sec id="suclg1-mtddepl.Genetically_Related_Allel">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with pathogenic variants in <italic toggle="yes">SUCLG1</italic>.</p>
      </sec>
      <sec id="suclg1-mtddepl.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><italic toggle="yes">SUCLG1</italic>-related mtDNA depletion syndrome needs to be differentiated from other mtDNA depletion syndromes, a genetically and clinically heterogeneous group of autosomal recessive disorders that are characterized by a severe reduction in mtDNA content leading to impaired energy production in affected tissues and organs. <xref ref-type="table" rid="suclg1-mtddepl.T.mitochondrial_dna_deple">Table 3</xref> includes the currently known mtDNA depletion syndromes.</p>
        <p>Mitochondrial DNA depletion syndromes occur as a result of defects in mtDNA maintenance caused by pathogenic variants in nuclear genes that function in either mitochondrial nucleotide synthesis (e.g., <italic toggle="yes">TK2</italic>, <italic toggle="yes">SUCLA2</italic>, <italic toggle="yes">SUCLG1</italic>, <italic toggle="yes">RRM2B</italic>, <italic toggle="yes">DGUOK</italic>, and <italic toggle="yes">TYMP</italic>) or mtDNA replication (e.g., <italic toggle="yes">POLG</italic> and <italic toggle="yes">TWNK</italic> [<italic toggle="yes">C10orf2</italic>]). The function of <italic toggle="yes">FBXL4</italic> is not yet known.</p>
        <p>Mitochondrial DNA depletion syndromes are phenotypically classified into hepatocerebral, encephalomyopathic, neurogastrointestinal, and myopathic forms [<xref ref-type="bibr" rid="suclg1-mtddepl.REF.elhattab.2013.186">El-Hattab &#x00026; Scaglia 2013</xref>].</p>
        <table-wrap id="suclg1-mtddepl.T.mitochondrial_dna_deple" orientation="portrait" position="anchor">
          <label>Table 3. </label>
          <caption>
            <p>Mitochondrial DNA Depletion Syndromes</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Phenotype&#x000a0;<sup>1</sup></th>
                <th id="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene</th>
                <th id="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Mitochondrial DNA Depletion Syndrome #, Type</th>
                <th id="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference&#x000a0;<sup>2</sup></th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_1" rowspan="5" valign="middle" align="left" scope="row" colspan="1">Hepato-cerebral</td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">DGUOK</italic>
                </td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">3, hepatocerebral type</td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">
                  <italic toggle="yes">POLG</italic>
                </td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">4A, Alpers type</td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="alpers" document-type="chapter"><italic toggle="yes">POLG</italic>-Related Disorders</related-object>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">
                  <italic toggle="yes">MPV17</italic>
                </td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">6, hepatocerebral type</td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="mpv17-mtdep" document-type="chapter"><italic toggle="yes">MPV17</italic>-Related Hepatocerebral mtDNA Depletion Syndrome</related-object>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1"><italic toggle="yes">TWNK</italic> (<italic toggle="yes">C10orf2</italic>)</td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">7, hepatocerebral type</td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/271245">271245</ext-link></td>
              </tr>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">
                  <italic toggle="yes">TFAM</italic>
                </td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">15, hepatocerebral type</td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://omim.org/entry/617156">617156</ext-link></td>
              </tr>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_1" rowspan="6" valign="middle" align="left" scope="row" colspan="1">Encephalo-<break/>myopathic</td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">SUCLA2</italic>
                </td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">5, encephalomyopathic type w/methylmalonic aciduria</td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="sucla2-def" document-type="chapter"><italic toggle="yes">SUCLA2</italic>-Related mtDNA Depletion Syndrome, Encephalomyopathic Form w/Methylmalonic Aciduria</related-object>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">
                  <italic toggle="yes">FBXL4</italic>
                </td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">13, encephalomyopathic type</td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="fbxl4-mtddepl" document-type="chapter"><italic toggle="yes">FBXL4</italic>-Related Encephalomyopathic mtDNA Depletion Syndrome</related-object>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">
                  <italic toggle="yes">SUCLG1</italic>
                </td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">9, encephalomyopathic type w/methylmalonic aciduria</td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">SUCLG1</italic>-Related mtDNA Depletion Syndrome, Encephalomyopathic Form w/Methylmalonic Aciduria</td>
              </tr>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">
                  <italic toggle="yes">RRM2B</italic>
                </td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">8A, encephalomyopathic type w/renal tubulopathy</td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="rrm2b-mtddepl" document-type="chapter"><italic toggle="yes">RRM2B</italic>-Related Mitochondrial Disease</related-object>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">
                  <italic toggle="yes">OPA1</italic>
                </td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">14, encephalocardiomyopathic type</td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/616896">616896</ext-link></td>
              </tr>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">
                  <italic toggle="yes">ABAT</italic>
                </td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Encephalomyopathic type</td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/613163">613163</ext-link></td>
              </tr>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">Neurogastro-<break/>intestinal</td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">TYMP</italic>
                </td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1, MNGIE type</td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="mngie" document-type="chapter">Mitochondrial Neurogastrointestinal Encephalopathy Disease</related-object>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">
                  <italic toggle="yes">POLG</italic>
                </td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">4B, MNGIE type</td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="alpers" document-type="chapter"><italic toggle="yes">POLG</italic>-Related Disorders</related-object>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">
                  <italic toggle="yes">RRM2B</italic>
                </td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">8B, MNGIE type</td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="rrm2b-mtddepl" document-type="chapter"><italic toggle="yes">RRM2B</italic>-Related Mitochondrial Disease</related-object>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_1" rowspan="4" valign="middle" align="left" scope="row" colspan="1">Myopathic</td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">TK2</italic>
                </td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">2, myopathic type</td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="tk2-mtddepl" document-type="chapter"><italic toggle="yes">TK2</italic>-Related mtDNA Depletion Syndrome, Myopathic Form</related-object>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">
                  <italic toggle="yes">AGK</italic>
                </td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">10, cardiomyopathic type (Sengers syndrome)</td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/212350">212350</ext-link></td>
              </tr>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">
                  <italic toggle="yes">MGME1</italic>
                </td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">11, myopathic type</td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/615084">615084</ext-link></td>
              </tr>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">
                  <italic toggle="yes">SLC25A4</italic>
                </td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">12B, cardiomyopathic type</td>
                <td headers="hd_h_suclg1-mtddepl.T.mitochondrial_dna_deple_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/615418">615418</ext-link></td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="suclg1-mtddepl.TF.3.1">
              <label>1. </label>
              <p>Within each phenotypic category, mtDNA depletion syndromes are ordered by relative prevalence.</p>
            </fn>
            <fn id="suclg1-mtddepl.TF.3.2">
              <label>2. </label>
              <p>See hyperlinked <italic toggle="yes">GeneReview</italic> or OMIM phenotype entry for more information.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>Among mtDNA depletion syndromes, methylmalonic acid (MMA) is elevated only in <italic toggle="yes">SUCLG1</italic>- and <italic toggle="yes">SUCLA2</italic>-related mtDNA depletion syndromes.</p>
        <p>The phenotypes of <italic toggle="yes">SUCLG1</italic>-related mtDNA depletion syndrome and <italic toggle="yes">SUCLA2</italic>-related mtDNA depletion syndrome may be difficult to be differentiate (see <xref ref-type="table" rid="suclg1-mtddepl.T.comparison_of_the_pheno">Table 4</xref>).</p>
        <p><italic toggle="yes">SUCLA2</italic>-related mtDNA depletion syndrome is characterized by onset of the following features in infancy or childhood: psychomotor retardation, hypotonia, dystonia, muscular atrophy, sensorineural hearing impairment, postnatal growth retardation, and feeding difficulties. Other less frequent features include distinctive facial features, contractures, kyphoscoliosis, gastroesophageal reflux, ptosis, choreoathetosis, ophthalmoplegia, and epilepsy. Of note, hepatopathy and cardiomyopathy, which have been reported in <italic toggle="yes">SUCLG1</italic>-related mtDNA depletion syndrome, have not been described in <italic toggle="yes">SUCLA2</italic>-related mtDNA depletion syndrome [<xref ref-type="bibr" rid="suclg1-mtddepl.REF.carrozzo.2016.243">Carrozzo et al 2016</xref>].</p>
        <table-wrap id="suclg1-mtddepl.T.comparison_of_the_pheno" orientation="portrait" position="anchor">
          <label>Table 4. </label>
          <caption>
            <p>Comparison of the Phenotypes of <italic toggle="yes">SUCLG1</italic>-Related mtDNA Depletion Syndrome and <italic toggle="yes">SUCLA2</italic>-Related mtDNA Deletion Syndromes</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_1" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Clinical Finding</th>
                <th id="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">SUCLG1</italic>-Related mtDNA Depletion Syndrome</th>
                <th id="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">SUCLA2</italic>-Related mtDNA Depletion Syndrome</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_1" valign="middle" colspan="2" align="left" scope="row" rowspan="1">Age at onset</td>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Majority present at birth</td>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Infancy or childhood</td>
              </tr>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_1" valign="middle" colspan="2" align="left" scope="row" rowspan="1">Median survival</td>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">20 months</td>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">20 years</td>
              </tr>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_1" valign="middle" colspan="2" align="left" scope="row" rowspan="1">Developmental delay</td>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;50%</td>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;75%</td>
              </tr>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_1" valign="middle" colspan="2" align="left" scope="row" rowspan="1">Hypotonia</td>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;50%</td>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;75%</td>
              </tr>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_1" valign="middle" colspan="2" align="left" scope="row" rowspan="1">Muscular atrophy</td>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;50%</td>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">25%-50%</td>
              </tr>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_1" valign="middle" colspan="2" align="left" scope="row" rowspan="1">Feeding problems</td>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_2 hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_3" valign="middle" colspan="2" align="center" rowspan="1">Equally common</td>
              </tr>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_1" valign="middle" colspan="2" align="left" scope="row" rowspan="1">Failure to thrive</td>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_2 hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_3" valign="middle" colspan="2" align="center" rowspan="1">Equally common</td>
              </tr>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_1" valign="middle" colspan="2" align="left" scope="row" rowspan="1">Liver involvement</td>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">40%</td>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Not reported</td>
              </tr>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_1" valign="middle" colspan="2" align="left" scope="row" rowspan="1">Hearing impairment</td>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">20%-50%</td>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;75%</td>
              </tr>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_1" valign="middle" colspan="2" align="left" scope="row" rowspan="1">Dystonia</td>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">25%-50%</td>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;75%</td>
              </tr>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_1" valign="middle" colspan="2" align="left" scope="row" rowspan="1">Hypertonia</td>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">25%-50%</td>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;20%</td>
              </tr>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_1" valign="middle" colspan="2" align="left" scope="row" rowspan="1">Hypertrophic cardiomyopathy</td>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">14%</td>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Not reported</td>
              </tr>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">Brain MRI</td>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">Basal ganglia hyperintensities</td>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">80%</td>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">70%</td>
              </tr>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Cerebral atrophy</td>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">30%</td>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">70%</td>
              </tr>
              <tr>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Leukoencephalopathy</td>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">20%</td>
                <td headers="hd_h_suclg1-mtddepl.T.comparison_of_the_pheno_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">15%</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>
                <xref ref-type="bibr" rid="suclg1-mtddepl.REF.carrozzo.2016.243">Carrozzo et al [2016]</xref>
              </p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="suclg1-mtddepl.Management">
        <title>Management</title>
        <sec id="suclg1-mtddepl.Evaluations_Following_Ini">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with <italic toggle="yes">SUCLG1</italic>-related mtDNA depletion syndrome the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Comprehensive neurologic examination and developmental/cognitive assessment. The following diagnostic modalities can be considered to assess the degree of neurologic involvement:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Brain MRI (if not performed during the diagnostic evaluation) to establish the degree of central nervous system involvement</p>
                </list-item>
                <list-item>
                  <p>EEG if seizures are suspected</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Echocardiogram to assess for cardiomyopathy</p>
            </list-item>
            <list-item>
              <p>Liver function tests including transaminases, albumin, total and direct bilirubin, and coagulation profile.</p>
            </list-item>
            <list-item>
              <p>Audiology evaluation</p>
            </list-item>
            <list-item>
              <p>Ophthalmologic examination for evidence of ptosis and/or strabismus</p>
            </list-item>
            <list-item>
              <p>Nutritional evaluation and swallowing assessment for feeding difficulties and growth failure</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="suclg1-mtddepl.Treatment_of_Manifestatio">
          <title>Treatment of Manifestations</title>
          <p>Management is best provided by a multidisciplinary team including specialists in neurology, audiology, child development, gastroenterology, cardiology, nutrition, and clinical genetics. Treatments include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Physical therapy to help maintain muscle function and prevent joint contractures</p>
            </list-item>
            <list-item>
              <p>Standard treatment with antiepileptic drugs for seizures</p>
            </list-item>
            <list-item>
              <p>Nutritional support by a dietitian and the use of a nasogastric tube or gastrostomy tube feedings to address feeding difficulties and failure to thrive</p>
            </list-item>
            <list-item>
              <p>Chest physiotherapy, aggressive antibiotic treatment of chest infections, and artificial ventilation (including assisted nasal ventilation or intubation and the use of a tracheostomy and ventilator) for respiratory insufficiency.</p>
            </list-item>
            <list-item>
              <p>Hypertrophic cardiomyopathy and hepatopathy, when present, require standard management by cardiologists and hepatologists, respectively.</p>
            </list-item>
          </list>
        </sec>
        <sec id="suclg1-mtddepl.Surveillance">
          <title>Surveillance</title>
          <p>No clinical guidelines for surveillance are available.</p>
          <p>The following evaluations are suggested, with frequency varying according to the needs of the child:</p>
          <list list-type="bullet">
            <list-item>
              <p>Developmental and neurologic assessment</p>
            </list-item>
            <list-item>
              <p>Nutritional and growth assessment</p>
            </list-item>
            <list-item>
              <p>Echocardiogram</p>
            </list-item>
            <list-item>
              <p>Liver function tests</p>
            </list-item>
            <list-item>
              <p>Hearing evaluation</p>
            </list-item>
            <list-item>
              <p>Ophthalmologic examination</p>
            </list-item>
          </list>
        </sec>
        <sec id="suclg1-mtddepl.Evaluation_of_Relatives_a">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="suclg1-mtddepl.Related_Genetic_Counselin">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="suclg1-mtddepl.Therapies_Under_Investiga">
          <title>Therapies Under Investigation</title>
          <p>A group of mtDNA depletion syndromes is caused by defects in genes encoding proteins involved in maintenance of the mitochondrial deoxyribonucleotide pool. Because in vitro experimental studies have demonstrated improved mtDNA content following deoxyribonucleotide supplementation, this could potentially be a treatment for some mtDNA depletion syndromes [<xref ref-type="bibr" rid="suclg1-mtddepl.REF.c_mara.2014.2459">C&#x000e1;mara et al 2014</xref>].</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="suclg1-mtddepl.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="suclg1-mtddepl.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">SUCLG1</italic>-related mitochondrial DNA (mtDNA) depletion syndrome, encephalomyopathic form with methylmalonic aciduria is inherited in an autosomal recessive manner.</p>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">SUCLG1</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Individuals with <italic toggle="yes">SUCLG1</italic>-related mtDNA depletion syndrome are not reported to reproduce.</p>
          <p><bold>Other family members.</bold> Each sib of the proband&#x02019;s parents is at a 50% risk of being a carrier of a <italic toggle="yes">SUCLG1</italic> pathogenic variant.</p>
        </sec>
        <sec id="suclg1-mtddepl.Carrier_Heterozygote_Dete">
          <title>Carrier (Heterozygote) Detection</title>
          <p>Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">SUCLG1</italic> pathogenic variants in the family.</p>
        </sec>
        <sec id="suclg1-mtddepl.Related_Genetic_Counselin">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="suclg1-mtddepl.Prenatal_Testing_and_Prei">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">SUCLG1</italic> pathogenic variants have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis are possible.</p>
        </sec>
      </sec>
      <sec id="suclg1-mtddepl.Resources">
        <title>Resources</title>
      </sec>
      <sec id="suclg1-mtddepl.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="suclg1-mtddepl.Molecular_Genetic_Pathoge">
          <title>Molecular Genetic Pathogenesis</title>
          <p>Succinyl-CoA ligase (SUCL) is a mitochondrial heterodimeric enzyme of the Krebs cycle that is composed of an alpha subunit, encoded by <italic toggle="yes">SUCLG1,</italic> and a beta subunit, encoded by either <italic toggle="yes">SUCLA2</italic> or <italic toggle="yes">SUCLG2</italic>. SUCL catalyzes the reversible conversion of succinyl-CoA and ADP or GDP to succinate and ATP or GTP. When the alpha subunit forms a heterodimer with <italic toggle="yes">SUCLA2</italic>-encoded beta subunits, the resulting SUCL enzyme utilizes ADP to generate ATP. In contrast, when the alpha subunit forms a heterodimer with <italic toggle="yes">SUCLG2</italic>-encoded beta subunits, the resulting SUCL enzyme utilizes GDP to generate GTP.</p>
          <p>SUCL also forms a complex with the mitochondrial nucleoside diphosphate kinase (see <bold>Abnormal gene product</bold>).</p>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">SUCLG1</italic> contains nine exons (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/NM_003849.3">NM_003849.3</ext-link>).</p>
          <p><bold>Pathogenic variants.</bold> The spectrum of reported <italic toggle="yes">SUCLG1</italic> pathogenic variants includes missense, splice site, frameshift deletion, and nonsense variants. Missense variants are the most common, accounting for about half of pathogenic variants.</p>
          <p><bold>Normal gene product.</bold>
<italic toggle="yes">SUCLG1</italic> encodes the succinyl-CoA ligase [ADP/GDP-forming] subunit alpha of SUCL, which has 346 amino acid residues (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/NP_003840.2">NP_003840.2</ext-link>).</p>
          <p><bold>Abnormal gene product.</bold> Pathogenic <italic toggle="yes">SUCLG1</italic> variants lead to dysfunctional SUCL protein. As SUCL forms a complex with the mitochondrial nucleoside diphosphate kinase, the lack of this complex in SUCL deficiency can disturb the kinase function, resulting in decreased mitochondrial nucleotide synthesis and, therefore, decreased mtDNA synthesis leading to mtDNA depletion. In addition, because SUCL deficiency results in impaired conversion of succinyl-CoA to succinate, succinyl-CoA accumulates and is converted to methylmalonyl-CoA by methylmalonyl-CoA mutase, leading to the accumulation of methylmalonic acid (MMA) [<xref ref-type="bibr" rid="suclg1-mtddepl.REF.elhattab.2013.186">El-Hattab &#x00026; Scaglia 2013</xref>].</p>
        </sec>
      </sec>
      <sec id="suclg1-mtddepl.References">
        <title>References</title>
        <sec id="suclg1-mtddepl.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="suclg1-mtddepl.Literature_Cited.reflist0">
            <ref id="suclg1-mtddepl.REF.c_mara.2014.2459">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>C&#x000e1;mara</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonz&#x000e1;lez-Vioque</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scarpelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torres-Torronteras</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caballero</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mart&#x000ed;</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Administration of deoxyribonucleosides or inhibition of their catabolism as a pharmacological approach for mitochondrial DNA depletion syndrome.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2014</year>
                <volume>23</volume>
                <fpage>2459</fpage>
                <lpage>67</lpage>
                <pub-id pub-id-type="pmid">24362886</pub-id>
              </element-citation>
            </ref>
            <ref id="suclg1-mtddepl.REF.carrozzo.2016.243">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carrozzo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verrigni</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rasmussen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Coo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amartino</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bianchi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buhas</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mesli</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naess</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Born</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woldseth</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prontera</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Batbayli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ravn</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joensen</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cordelli</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santorelli</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tulinius</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duno</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jouvencel</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burlina</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stangoni</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Redonnet-Vernhet</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wibrand</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dionisi-Vici</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uusimaa</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vieira</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osorio</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McFarland</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holme</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ostergaard</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>Succinate-CoA ligase deficiency due to mutations in SUCLA2 and SUCLG1: phenotype and genotype correlations in 71 patients.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2016</year>
                <volume>39</volume>
                <fpage>243</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">26475597</pub-id>
              </element-citation>
            </ref>
            <ref id="suclg1-mtddepl.REF.chu.2016.264">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pupavac</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watkins</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tian</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feng</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fenter</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>VW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <article-title>Next generation sequencing of patients with mut methylmalonic aciduria: Validation of somatic cell studies and identification of 16 novel mutations.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2016</year>
                <volume>118</volume>
                <fpage>264</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">27233228</pub-id>
              </element-citation>
            </ref>
            <ref id="suclg1-mtddepl.REF.donti.2016.68">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Donti</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masand</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Craigen</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>BH</given-names>
                  </name>
                </person-group>
                <article-title>Expanding the phenotypic spectrum of Succinyl-CoA ligase deficiency through functional validation of a new SUCLG1 variant.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2016</year>
                <volume>119</volume>
                <fpage>68</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">27484306</pub-id>
              </element-citation>
            </ref>
            <ref id="suclg1-mtddepl.REF.elhattab.2013.186">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>El-Hattab</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scaglia</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options.</article-title>
                <source>Neurotherapeutics.</source>
                <year>2013</year>
                <volume>10</volume>
                <fpage>186</fpage>
                <lpage>98</lpage>
                <pub-id pub-id-type="pmid">23385875</pub-id>
              </element-citation>
            </ref>
            <ref id="suclg1-mtddepl.REF.honzik.2012.749">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Honzik</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tesarova</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayr</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jesina</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vesela</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wenchich</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szentivanyi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hansikova</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperl</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeman</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Neonatal onset of mitochondrial disorders in 129 patients: clinical and laboratory characteristics and a new approach to diagnosis.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2012</year>
                <volume>35</volume>
                <fpage>749</fpage>
                <lpage>59</lpage>
                <pub-id pub-id-type="pmid">22231385</pub-id>
              </element-citation>
            </ref>
            <ref id="suclg1-mtddepl.REF.landsverk.2014">
              <mixed-citation publication-type="other">Landsverk ML, Zhang VW, Wong LC, Andersson HC. A SUCLG1 mutation in a patient with mitochondrial DNA depletion and congenital anomalies. Mol Genet Metab Rep. 2014;1:451-4. eCollection 2014.</mixed-citation>
            </ref>
            <ref id="suclg1-mtddepl.REF.liu.2016.61">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ding</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>Y.</given-names>
                  </name>
                </person-group>
                <article-title>Five novel SUCLG1 mutations in three Chinese patients with succinate-CoA ligase deficiency noticed by mild methylmalonic aciduria.</article-title>
                <source>Brain Dev.</source>
                <year>2016</year>
                <volume>38</volume>
                <fpage>61</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">26028457</pub-id>
              </element-citation>
            </ref>
            <ref id="suclg1-mtddepl.REF.navarrosastre.2012.409">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Navarro-Sastre</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tort</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia-Villoria</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pons</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nascimento</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colomer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campistol</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoldi</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f3;pez-Gallardo</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montoya</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Unceta</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Briones</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ribes</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Mitochondrial DNA depletion syndrome: new descriptions and the use of citrate synthase as a helpful tool to better characterise the patients.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2012</year>
                <volume>107</volume>
                <fpage>409</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">22980518</pub-id>
              </element-citation>
            </ref>
            <ref id="suclg1-mtddepl.REF.ostergaard.2007.383">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ostergaard</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christensen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kristensen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mogensen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duno</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shoubridge</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wibrand</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Deficiency of the alpha subunit of succinate-coenzyme A ligase causes fatal infantile lactic acidosis with mitochondrial DNA depletion.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2007</year>
                <volume>81</volume>
                <fpage>383</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17668387</pub-id>
              </element-citation>
            </ref>
            <ref id="suclg1-mtddepl.REF.ostergaard.2010.201">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ostergaard</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Batbayli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christensen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hjalmarson</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kollberg</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holme</surname>
                    <given-names>E.</given-names>
                  </name>
                </person-group>
                <article-title>A novel missense mutation in SUCLG1 associated with mitochondrial DNA depletion, encephalomyopathic form, with methylmalonic aciduria.</article-title>
                <source>Eur J Pediatr.</source>
                <year>2010</year>
                <volume>169</volume>
                <fpage>201</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">19526370</pub-id>
              </element-citation>
            </ref>
            <ref id="suclg1-mtddepl.REF.pupavac.2016.363">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pupavac</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tian</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feng</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fenter</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>VW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watkins</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <article-title>Added value of next generation gene panel analysis for patients with elevated methylmalonic acid and no clinical diagnosis following functional studies of vitamin B12 metabolism.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2016</year>
                <volume>117</volume>
                <fpage>363</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">26827111</pub-id>
              </element-citation>
            </ref>
            <ref id="suclg1-mtddepl.REF.randolph.2011.149">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Randolph</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimada</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanchez-Lara</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boles</surname>
                    <given-names>RG</given-names>
                  </name>
                </person-group>
                <article-title>Fatal infantile lactic acidosis and a novel homozygous mutation in the SUCLG1 gene: a mitochondrial DNA depletion disorder.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2011</year>
                <volume>102</volume>
                <fpage>149</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">21093335</pub-id>
              </element-citation>
            </ref>
            <ref id="suclg1-mtddepl.REF.rivera.2010.362">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rivera</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merinero</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez-Pardo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arroyo</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruiz-Sala</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bornstein</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serra-Suhe</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallardo</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marti</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moran</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ugalde</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perez-Jurado</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andreu</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garesse</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ugarte</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arenas</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <article-title>Marked mitochondrial DNA depletion associated with a novel SUCLG1 gene mutation resulting in lethal neonatal acidosis, multi-organ failure, and interrupted aortic arch.</article-title>
                <source>Mitochondrion.</source>
                <year>2010</year>
                <volume>10</volume>
                <fpage>362</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">20227526</pub-id>
              </element-citation>
            </ref>
            <ref id="suclg1-mtddepl.REF.rouzier.2010.670">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rouzier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Gu&#x000e9;dard-M&#x000e9;reuze</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fragaki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serre</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miro</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuffery-Giraud</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaussenot</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bannwarth</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caruba</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ostergaard</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pellissier</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richelme</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Espil</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chabrol</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paquis-Flucklinger</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <article-title>The severity of phenotype linked to SUCLG1 mutations could be correlated with residual amount of SUCLG1 protein.</article-title>
                <source>J Med Genet.</source>
                <year>2010</year>
                <volume>47</volume>
                <fpage>670</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">20693550</pub-id>
              </element-citation>
            </ref>
            <ref id="suclg1-mtddepl.REF.sakamoto.2011.921">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sakamoto</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murayama</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohtake</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harashima</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abukawa</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takeyama</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haginoya</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyabayashi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kure</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Neonatal lactic acidosis with methylmalonic aciduria due to novel mutations in the SUCLG1 gene.</article-title>
                <source>Pediatr Int.</source>
                <year>2011</year>
                <volume>53</volume>
                <fpage>921</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">21639866</pub-id>
              </element-citation>
            </ref>
            <ref id="suclg1-mtddepl.REF.valayannopoulos.2010.335">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Valayannopoulos</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haudry</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serre</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barth</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boddaert</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnoux</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cormier-Daire</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rabier</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vassault</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonnefont</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Lonlay</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>R&#x000f6;tig</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lebre</surname>
                    <given-names>AS</given-names>
                  </name>
                </person-group>
                <article-title>New SUCLG1 patients expanding the phenotypic spectrum of this rare cause of mild methylmalonic aciduria.</article-title>
                <source>Mitochondrion.</source>
                <year>2010</year>
                <volume>10</volume>
                <fpage>335</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">20197121</pub-id>
              </element-citation>
            </ref>
            <ref id="suclg1-mtddepl.REF.van_hove.2010.159">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Van Hove</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saenz</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallagher</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lovell</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fenton</surname>
                    <given-names>LZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shanske</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myers</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wanders</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruiter</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turkenburg</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waterham</surname>
                    <given-names>HR</given-names>
                  </name>
                </person-group>
                <article-title>Succinyl-CoA ligase deficiency: a mitochondrial hepatoencephalomyopathy.</article-title>
                <source>Pediatr Res.</source>
                <year>2010</year>
                <volume>68</volume>
                <fpage>159</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">20453710</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="suclg1-mtddepl.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="suclg1-mtddepl.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>30 March 2017 (bp) Review posted live</p>
            </list-item>
            <list-item>
              <p>20 October 2016 (aeh) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
